Skip to content

LimGame

  • About Us
  • Contact Us
  • Disclaimer
  • New Page (ID #11032)
  • Privacy Policy
LimGame
  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    Boeing’s Revenue Climbs Past Estimates

    By2oo7m April 23, 2025

    Boeing, a leading aerospace manufacturer renowned for its commercial airplane production, released its Q1 2025 earnings on April 23, 2025. The earnings report showcased results that beat analyst expectations, reflecting ongoing efforts to stabilize its operations. Revenue for Q1 2025 reached $19.5 billion (GAAP), surpassing the analyst estimate of $19.38 billion, driven primarily by increased…

    Read More Boeing’s Revenue Climbs Past EstimatesContinue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    Forget Zepbound: Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

    By2oo7m April 23, 2025

    Eli Lilly (NYSE: LLY) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a weight loss medicine that’s already generating more than $1 billion in quarterly sales, although it was approved only in late 2023. Zepbound’s prospects still look bright, but some recent developments point…

    Read More Forget Zepbound: Eli Lilly Has Its Next Billion-Dollar Weight Loss DrugContinue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    Should Investors Buy Palantir Stock Before May 5?

    By2oo7m April 22, 2025

    Palantir (NASDAQ: PLTR) is impressing stock market investors with its phenomenal growth in its enterprise segment. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More ยป *Stock prices used were the afternoon prices of April 19, 2025. The video…

    Read More Should Investors Buy Palantir Stock Before May 5?Continue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    Should You Buy Alphabet Stock Before April 24?

    By2oo7m April 22, 2025

    Over the next few weeks, many companies are scheduled to report earnings for the first calendar quarter of 2025. For the technology sector, perhaps no other companies are as important as the “Magnificent Seven” — Nvidia, Apple, Microsoft, Amazon, Meta Platforms, Tesla, and Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG). These businesses have unlocked new forms of…

    Read More Should You Buy Alphabet Stock Before April 24?Continue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    Stock Market Sell Off: 3 No-Brainer Dividend Stocks to Buy If You Want to Get Paid

    By2oo7m April 22, 2025

    If you are watching the market volatility and worried about the future, you might want to shift the way you look at things. An easy win is to add some dividend-paying stocks to your portfolio so you can pay attention to dividend checks instead of the ups and downs of the S&P 500 index. Three…

    Read More Stock Market Sell Off: 3 No-Brainer Dividend Stocks to Buy If You Want to Get PaidContinue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    Nvidia Investors Shocked After Amazon Data Center Updates

    By2oo7m April 22, 2025

    In today’s video, I discuss Nvidia (NASDAQ: NVDA) and recent updates affecting the semiconductor market. To learn more, check out the short video, consider subscribing, and click the special offer link below. *Stock prices used were the after-market prices of April 21, 2025. The video was published on April 21, 2025. Where to invest $1,000…

    Read More Nvidia Investors Shocked After Amazon Data Center UpdatesContinue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

    By2oo7m April 22, 2025

    When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However, you don’t necessarily have to sacrifice growth for safety. Three Fool.com contributors believe they’ve identified relatively safe growth stocks in the healthcare sector that you can buy and hold. Here’s why they picked Amgen (NASDAQ:…

    Read More 3 Relatively Safe Healthcare Growth Stocks You Can Buy and HoldContinue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    5 Strategies for Avoiding RMD Errors

    By2oo7m April 21, 2025

    If you’ve been tucking money away into a traditional IRA, SEP IRA, SIMPLE IRA, or employer-sponsored plan like a 401(k), you’ll eventually have to take required minimum distributions (RMDs) and pay taxes on the money withdrawn. Generally, RMDs kick in the year you turn 73 (or 75, if you were born in 1960 or later)….

    Read More 5 Strategies for Avoiding RMD ErrorsContinue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    Here’s Why Enterprise Products Partners Stock Is a Buy Before April 29

    By2oo7m April 21, 2025

    Enterprise Products Partners (NYSE: EPD), one of the largest midstream natural gas and crude oil pipeline companies in America, is usually considered a slow-growth stock. But over the past five years, this boring but reliable income stock rallied about 93%. If we include its reinvested distributions, it generated a total return of 187%. During that…

    Read More Here’s Why Enterprise Products Partners Stock Is a Buy Before April 29Continue

  • Debt Management & Credit | Financial Planning & Retirement | Side Hustles & Passive Income

    Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?

    By2oo7m April 21, 2025

    Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019. Yet the stock has since plummeted 61% from its peak value. Despite strong growth and earnings momentum, the Danish biotech giant faces scrutiny over its positioning in the rapidly changing market for GLP-1 receptor…

    Read More Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?Continue

Page navigation

Previous PagePrevious 1 … 27 28 29 30 31 … 62 Next PageNext

© 2025 LimGame - WordPress Theme by Kadence WP

  • About Us
  • Contact Us
  • Disclaimer
  • New Page (ID #11032)
  • Privacy Policy